Mirada Solutions of Oxford, U.K., has signed an agreement to develop image analysis software to support molecular diagnostic products from Amersham Health of Buckinghamshire, U.K. The product will be based on Mirada’s existing MiraView multimodality workstation technology. The initial agreement covers two projects, and both parties believe that the technology could be used in conjunction with a number of other molecular diagnostics efforts, according to Mirada.
By AuntMinnie.com staff writersFebruary 6, 2003
Related Reading
Amersham gets FDA approval for Irish facility, July 11, 2002
Amersham, Premier extend brachytherapy seed agreements, July 2, 2002
Amersham to market Optison in Europe, June 6, 2002
Amersham inks supply deal with Novation, May 29, 2002
Amersham shows uptick in Q1 numbers, April 29, 2002
Copyright © 2003 AuntMinnie.com
